Page 9 - JCBP-1-1
P. 9

Journal of Clinical and

                                                                   Basic Psychosomatics



                                        REVIEW ARTICLE
                                        Pharmacological treatment-associated brain

                                        structural and functional alterations in major
                                        depressive disorder: A narrative review



                                                                 1
                                                  1,2
                                                                                 1
                                        Lulu Zhang , Jingping Zhao , and Wenbin Guo *
                                        1 Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National
                                        Center for Mental Disorders, The Second Xiangya Hospital of Central South University, Changsha,
                                        Hunan, China
                                        2 Department of Psychiatry, Guangzhou First People’s Hospital, the Second Affiliated Hospital, South
                                        China University of Technology, Guangzhou, Guangdong, China


                                        Abstract

                                        Major depressive disorder (MDD) is a complicated mental disorder with an unclear
                                        etiology and a relatively limited response to treatment. Magnetic resonance imaging
                                        (MRI) can help identify the underlying neuropathophysiological mechanisms of MDD.
                                        A better understanding of structural and functional alterations in the brain before
                                        and after treatment is necessary to improve treatment targets at the brain level.
                                        This narrative review summarizes the literature on longitudinal MRI studies in MDD,
                                        which identify brain regions with changes in neural activity after antidepressant
                                        treatment, providing an objective imaging basis for early diagnosis and assessment
                                        of the efficacy of antidepressant therapy. It was found that the neural activity in the
                                        prefrontal cortex, cingulate cortex, precuneus, and hippocampus was reduced in
            *Corresponding author:      patients with untreated MDD. In addition, functional connectivity of the default mode
            Wenbin Guo                  network (DMN), central executive, and salience networks was enhanced, gray matter
            (guowenbin76@csu.edu.cn)    volume was reduced, and white matter structure was damaged. After antidepressant
            Citation: Zhang L, Zhao J, Guo W,   treatment, neural activity in some brain regions increased and functional connectivity
            Pharmacological treatment-associated   of brain networks and gray and white matter structures returned to normal states.
            brain structural and functional
            alterations in major depressive   Although the results have been inconsistent, amygdala hypoactivation and anterior
            disorder: A narrative review. Journal   cingulate cortex hyperactivation in response to negative emotional stimuli are
            of Clinical and Basic Psychosomatics.   promising predictors of successful treatment, and hyperconnectivity within and
            1(1): 0896
            https://doi.org/10.36922/jcbp.0896  between the DMN and executive control network exhibit similar results.
            Received: May 4, 2023
            Accepted: July 5, 2023      Keywords: Major depressive disorder; Magnetic resonance imaging; Neuroimaging;
                                        Antidepressants; Treatment
            Published Online: July 21, 2023
            Copyright: © 2023 Author(s).
            This is an Open Access article
            distributed under the terms of the   1. Introduction
            Creative Commons Attribution
            License, permitting distribution,   Major depressive disorder (MDD) is a leading cause of disability and contributes to
            and reproduction in any medium,
            provided the original work is   the global disease burden. About 4 – 7% (95% uncertainty interval 4.4 – 5.0) of the
            properly cited.             world’s population have an episode of depression in any 12-month time period . The
                                                                                                        [1]
                                                                                                           [2]
            Publisher’s Note: AccScience   disorder is characterized by depressed mood, anhedonia, and cognitive impairment .
            Publishing remains neutral with   The pathogenesis of MDD is unclear but appears to involve various factors, such as
            regard to jurisdictional claims in
            published maps and institutional   the presence of neurotransmitters, neurohormonal dysregulation, neuroplasticity,
            affiliations.               and immune inflammation [3-8] . The primary sources of the three aforementioned

            Volume 1 Issue 1 (2023)                         1                        https://doi.org/10.36922/jcbp.0896
   4   5   6   7   8   9   10   11   12   13   14